Evidence map›Paper›PMID 34684184›Full record

ReviewPathogens (Basel, Switzerland)2021

Targeting Inflammation Driven by HMGB1 in Bacterial Keratitis-A Review.

Linda D Hazlett, Sharon McClellan, Mallika Somayajulu, Denise Bessert

Open access · goldAbstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. The Role ofPharmaceutics · 2024
    Review
  4. Article
  5. Article
  6. Metabolites Profiling and Bioassays RevealAntioxidants (Basel, Switzerland) · 2023
    Article
  7. PMFrontiers in cellular and infection microbiology · 2023
    Article
  8. Article
  9. Glycyrrhizin Interacts with TLR4 and TLR9 to ResolvePathogens (Basel, Switzerland) · 2022
    Article
  10. Ocular Surface Infection Mediated Molecular Stress Responses: A Review.International journal of molecular sciences · 2022
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Linda D HazlettDepartment of Ophthalmology, Visual and Anatomical Sciences, School of Medicine, Wayne State University, Detroit, MI 48201, USA.ORCID 0000-0003-1530-3242
Sharon McClellanDepartment of Ophthalmology, Visual and Anatomical Sciences, School of Medicine, Wayne State University, Detroit, MI 48201, USA.
Mallika SomayajuluDepartment of Ophthalmology, Visual and Anatomical Sciences, School of Medicine, Wayne State University, Detroit, MI 48201, USA.
Denise BessertDepartment of Ophthalmology, Visual and Anatomical Sciences, School of Medicine, Wayne State University, Detroit, MI 48201, USA.
Wayne State University · US

Funding

National Institutes of Health R01 EY016058 and P30 EY040468
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-HMGB1 antibodyblockade of receptorsglycyrrhizinHMGB1HMGB1 box AkeratitisPseudomonas aeruginosasilencing HMGB1thrombomodulinVIP

Identifiers

PMID34684184
PMCPMC8538492
OpenAlexW3202357992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.